文献速递乳腺MRUS

靶向乳腺超声病灶经皮取样后超声与MRI的相关性:用于术后标记夹定位的有限序列平扫MRI初步经验

Sonographic-MRI Correlation After Percutaneous Sampling of Targeted Breast Ultrasound Lesions: Initial Experiences With Limited-Sequence Unenhanced MRI for Postprocedural Clip Localization.
PubMed 文献 · AJR Am J Roentgenol · 2018-02-28

研究回顾性分析35例患者38个疑似超声相关灶,经超声引导取样后行有限序列平扫MRI验证标记夹位置,发现26%的疑似超声相关灶与MRI原病灶位置不一致,其中1例不一致病例后续MRI引导活检证实恶性。作者提醒放射科医生不应假定超声所见病灶即为MRI所见的可疑病灶,标记夹验证MRI可能有用。

要点

  • 26%的疑似超声相关灶经术后MRI标记夹验证并非MRI原病灶,其中10%不一致病例最终为恶性。
  • 有限序列平扫MRI(T1加权非脂肪饱和与T2加权脂肪饱和序列)可用于术后标记夹定位验证。
  • 未发现患者或病灶特征与超声-MRI相关性频率有显著关联。

核心结论

  • 在作者的初步经验中,26%的疑似超声相关灶并非MRI可疑病灶的实际对应灶,这些不一致病例中10%最终证实为恶性;放射科医生不应假定超声所见病灶即为MRI所见的可疑病灶,超声引导取样后行标记夹验证MRI可能有用。

研究设计与样本

  • 回顾性研究,2014年1月1日至2016年3月31日期间共1947次增强乳腺MRI检查和245次靶向超声检查,最终纳入35例患者38个疑似超声相关灶,均行超声引导取样及术后有限序列平扫MRI(T1加权非脂肪饱和序列与T2加权脂肪饱和序列)用于标记夹定位。

诊断标准与关键数值

  • 38个疑似超声相关灶中10个(26%)定位到与MRI原病灶不同的部位。
  • 10个不一致病例中1个(10%)后续MRI引导活检证实恶性,而超声疑似相关灶为良性。

临床应用与阅片要点

  • 作者提醒放射科医生不应假定超声所识别的病灶就是MRI所检测到的可疑病灶。
  • 作者认为若进行超声引导取样,用于标记夹验证的MRI可能有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to determine the frequency of correlation of sonographic and MRI findings after percutaneous sampling of presumed ultrasound correlates to suspicious lesions detected on breast MRI and to describe our initial experiences with limited-sequence MRI for postprocedural clip verification.

MATERIALS AND METHODS: Between January 1, 2014, and March 31, 2016, a total of 1947 contrast-enhanced breast MRI examinations were performed, and 245 targeted ultrasound examinations were conducted to identify correlates to suspicious MRI findings. We retrospectively identified all lesions that underwent ultrasound-guided sampling of a presumed sonographic correlate and for which a subsequent postprocedural limited-sequence unenhanced MR image for clip localization was available. This consisted of a T1-weighted non-fat-saturated and a T2-weighted fat-saturated sequence. Frequencies of sonographic-MRI correlation were quantified.

RESULTS: The study cohort consisted of 35 patients with 38 presumed correlates that underwent ultrasound-guided sampling with postprocedural MRI for clip verification. The mean time from percutaneous sampling to postprocedural MRI examination was 1 day. Ten presumed sonographic correlates (26%) were found to localize to a site distinct from the lesion originally identified on MRI. One of these discordant cases revealed malignancy on subsequent MRI-guided biopsy, whereas the presumed sonographic correlate was found to be benign. No patient or lesion characteristics were associated with significantly different frequencies of correlation.

CONCLUSION: In our initial experiences with MRI performed for postprocedural clip verification, 26% of presumed correlates to suspicious lesions detected on MRI were not the actual correlate, and 10% of these discordant cases ultimately revealed malignancy. Radiologists should take caution presuming that lesions identified on ultrasound actually represent the suspicious lesions detected on MRI. MRI for clip verification may be useful if ultrasound-guided sampling is pursued.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lee AY, Nguyen VT, Arasu VA, et al. Sonographic-MRI Correlation After Percutaneous Sampling of Targeted Breast Ultrasound Lesions: Initial Experiences With Limited-Sequence Unenhanced MRI for Postprocedural Clip Localization. AJR Am J Roentgenol. 2018. PMID: 29489404. doi:10.2214/AJR.17.18489

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。